A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor.
Montembault M, Vo-Thanh G, Deyine A, Fargeas V, Villiéras M, Adjou A, Dubreuil D, Esquieu D, Grégoire C, Opi S, Péloponèse JM, Campbell G, Watkins J, de Mareuil J, Aubertin AM, Bailly C, Loret E, Lebreton J.
Montembault M, et al. Among authors: gregoire c.
Bioorg Med Chem Lett. 2004 Mar 22;14(6):1543-6. doi: 10.1016/j.bmcl.2003.12.095.
Bioorg Med Chem Lett. 2004.
PMID: 15006399